Research and experimental development on natural sciences and engineering
ADJUTEC PHARMA AS
Operating profit
NOK −2.1m
Equity
NOK 33.3m
Incorporated
2019
Employees
5
Share capital
NOK 58,000
Roles
Daglig lederJethro Lee Holter
Regnskapsfører
Revisor
Styrets lederØyvind Kongstun Arnesen
StyremedlemPål Rongved
StyremedlemKjell Erik Nordby
StyremedlemAntonius Franciscus Berkien
StyremedlemNicolaj Refshall Weiergang
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| PATIAS INNOVATION AS | 49.2% | 24128.000000 | 2025 |
| KISTEFOS AS | 9.4% | 4620.000000 | 2025 |
| INVEN2 AS | 5.4% | 2648.000000 | 2025 |
| HELENE SUNDT AS | 4.9% | 2386.000000 | 2025 |
| WEIERGANGART AS | 3.2% | 1588.000000 | 2025 |
| TRYLLEBO AS | 3.2% | 1550.000000 | 2025 |
| HØSE AS | 3.1% | 1511.000000 | 2025 |
| CGS HOLDING AS | 2.4% | 1176.000000 | 2025 |
| LEMUREN AS | 2.3% | 1145.000000 | 2025 |
| WEIER AS | 2.1% | 1020.000000 | 2025 |
| RADFORSK INVESTERINGSSTIFTELSE | 1.7% | 837.000000 | 2025 |
| SUNDT AS | 1.5% | 726.000000 | 2025 |
| FARVATN VENTURE AS | 1.5% | 718.000000 | 2025 |
| ADJUTEC PHARMA AS | 1.4% | 706.000000 | 2025 |
| JANDERSEN KAPITAL AS | 1.4% | 664.000000 | 2025 |
| MYRLID AS | 1.4% | 664.000000 | 2025 |
| WIBO CONSULTING AS | 1.1% | 546.000000 | 2025 |
| KEN HOLDING AS | 1.1% | 530.000000 | 2025 |
| STAR KAPITAL AS | 1.0% | 506.000000 | 2025 |
| OSLO CANCER CLUSTER INCUBATOR AS | 0.7% | 353.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| ADJUTEC PHARMA AS | Active | 1.4% | 706.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.